BIO-TECHNE Corp (TECH) Stock Price Today
Key Stats
- $11.04BMARKET_CAP
- -VOLUME
- HealthSECTOR
- $71.38FIFTY_TWO_WEEK_HIGH
- $43.31FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $11.12BENTERPRISE_VALUE
- 0.45%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $71.38, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Most Recent News
SK Telecom plans 15GW AI data center in Korea, aiming to lead Asia's AI infrastructure by 2029.
SK Telecom announced plans to build an AI data center with a total capacity of 15GW, starting with 5GW to be activated in stages from 2029. This project aims to position Korea as a leading AI infrastructure hub in Asia, leveraging SK Group's full-sta...
Pepeto launches major security upgrade as XRP whales back its fast-growing DeFi presale in 2026.
Pepeto has completed a significant security upgrade on its DeFi exchange platform, drawing strong interest from XRP whale investors during its rapidly filling 2026 presale. This surge is linked to bullish XRP price forecasts and upcoming pro-crypto p...
Simply Solventless delays financial filings to July amid creditor proceedings and requests trade restrictions extension.
Simply Solventless Concentrates Ltd. announced a delay in filing its audited annual financial statements for 2025 and Q1 2026 reports, now expected by July 17 and July 24, respectively. The delay is due to management's focus on creditor proceedings i...
